Harvard 2012 endowment return trails Stanford, Yale

Modestly stronger investment results at peer institutions

Stanford and Yale, whose diversified endowment investment portfolios are similar to that of Harvard Management Company's (HMC), reported fiscal year 2012 investment returns somewhat above the nearly-flat University results reported earlier this week. 

As noted, HMC earned a -0.05 return on investments in the year ended June 30, and the endowment declined in value from $32 billion to $30.7 billion, reflecting spending to support University operations and other distributions.

Stanford Management Company reported a positive 1.0 percent investment return. The endowment increased in value by 3.2 percent, to $17 billion, reflecting investment gains and gifts received (the latter, a large sum, reflecting a recent capital campaign that raised $6.2 billion), and endowment distributions of $872 million (about half of Harvard's estimated endowment distribution during the year). That distribution is budgeted to increase 5.4 percent during the current year.

Yale, which in many respects pioneered the current model of highly diversified endowment investing—with heavy reliance on illiquid investment such as private equity, hedge funds, real estate, and other real assets—reported a 4.7 percent investment return for fiscal 2012. But Yale's endowment, like Harvard's, declined—albeit more modestly, from $19.4 billion to $19.3 billion in New Haven during the course of the year. That result reflects spending distributions from the endowment of approximately $1 billion,  Yale reported—about 36 percent of that institution's revenues.

Yale's annualized rate of investment return for the past 10 years now stands at 10.6 percent; for the past 20 years, it is 13.7 percent. Stanford's comparable 10-year rate of return is 9.7 percent. HMC's returns are 9.5 percent (10 years) and 12.3 percent (20 years).

 

 

You might also like

FAS Cuts Science Ph.D. Admissions By Half

Backing off plans for more drastic reductions, the division still faces a long-term deficit.

Harvard Divinity School Sets New Priorities

After two years of turmoil, Dean Marla Frederick describes a more pluralistic future for the institution’s culture and curriculum.

From Jellyfish to Digital Hearts

How Harvard researchers are helping to build a virtual model of the human heart

Most popular

The Life of a Harvard Spy

Richard Skeffington Welch’s illustrious—and clandestine—career in the CIA

Parks and Rec Comedy Writer Aisha Muharrar Gets Serious about Grief

With Loved One, the Harvard grad and Lampoon veteran makes her debut as a novelist.

This Harvard Scientist Is Changing the Future of Genetic Diseases

David Liu has pioneered breakthroughs in gene editing, creating new therapies that may lead to cures.

Explore More From Current Issue

A lively concert in a modern auditorium with an audience seated on multiple levels.

Concerts and Carols at the Isabella Stewart Gardner Museum

Tuning into one of Boston's best chamber music halls 

Professor David Liu smiles while sitting at a desk with colorful lanterns and a figurine in the background.

This Harvard Scientist Is Changing the Future of Genetic Diseases

David Liu has pioneered breakthroughs in gene editing, creating new therapies that may lead to cures.

A vibrant bar scene with tropical decor, featuring patrons sitting on high stools.

Best Bars for Seasonal Drinks and Snacks in Greater Boston

Gathering spots that warm and delight us